Loomis, Sayles & Company’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.4K Sell
200
-229
-53% -$63.4K ﹤0.01% 616
2025
Q4
$118K Buy
429
+328
+325% +$92K ﹤0.01% 568
2025
Q3
$29.1K Buy
101
+2
+2% +$592 ﹤0.01% 672
2025
Q2
$32.7K Sell
99
-21
-18% -$6.77K ﹤0.01% 657
2025
Q1
$39K Sell
120
-105
-47% -$31.6K ﹤0.01% 654
2024
Q4
$62K Sell
225
-21
-9% -$6.69K ﹤0.01% 625
2024
Q3
$85K Buy
246
+43
+21% +$14.8K ﹤0.01% 566
2024
Q2
$67K Buy
203
+4
+2% +$1.38K ﹤0.01% 594
2024
Q1
$72K Sell
199
-16
-7% -$5.27K ﹤0.01% 574
2023
Q4
$64K Sell
215
-4
-2% -$1.17K ﹤0.01% 581
2023
Q3
$63K Buy
219
+31
+16% +$8.84K ﹤0.01% 578
2023
Q2
$53K Buy
188
+7
+4% +$1.82K ﹤0.01% 602
2023
Q1
$46K Buy
181
+75
+71% +$21.9K ﹤0.01% 629
2022
Q4
$35K Buy
106
+44
+71% +$13.9K ﹤0.01% 658
2022
Q3
$17K Sell
62
-43
-41% -$12.1K ﹤0.01% 621
2022
Q2
$28K Sell
105
-14
-12% -$3.61K ﹤0.01% 574
2022
Q1
$29K Sell
119
-27
-18% -$6.32K ﹤0.01% 609
2021
Q4
$34K Sell
146
-51
-26% -$10.8K ﹤0.01% 630
2021
Q3
$39K Buy
197
+3
+2% +$652 ﹤0.01% 613
2021
Q2
$46K Buy
194
+15
+8% +$3.75K ﹤0.01% 590
2021
Q1
$43K Buy
179
+20
+13% +$4.46K ﹤0.01% 572
2020
Q4
$33K Sell
159
-4,362
-96% -$856K ﹤0.01% 580
2020
Q3
$766K Sell
4,521
-605
-12% -$106K ﹤0.01% 477
2020
Q2
$962K Buy
5,126
+4,975
+3,295% +$944K ﹤0.01% 459
2020
Q1
$27K Sell
151
-525
-78% -$102K ﹤0.01% 568
2019
Q4
$138K Buy
676
+61
+10% +$11.2K ﹤0.01% 550
2019
Q3
$93K Buy
+615
New +$100K ﹤0.01% 556
2019
Q2
Sell
-21,950
Closed -$3.53M 594
2019
Q1
$3.53M Buy
21,950
+10,711
+95% +$1.96M 0.01% 465
2018
Q4
$2.13M Buy
+11,239
New +$2.34M 0.01% 505
2018
Q3
Sell
-152
Closed -$26K 897
2018
Q2
$26K Buy
152
+18
+13% +$3.12K ﹤0.01% 727
2018
Q1
$22K Hold
134
﹤0.01% 765
2017
Q4
$27K Buy
134
+88
+191% +$17.5K ﹤0.01% 729
2017
Q3
$9K Hold
46
﹤0.01% 795
2017
Q2
$8K Buy
+46
New +$7.39K ﹤0.01% 810
2016
Q2
Sell
-3,900
Closed -$535K 1023
2016
Q1
$535K Sell
3,900
-1,894
-33% -$260K ﹤0.01% 611
2015
Q4
$848K Hold
5,794
﹤0.01% 594
2015
Q3
$782K Sell
5,794
-1,318
-19% -$191K ﹤0.01% 572
2015
Q2
$1.15M Hold
7,112
﹤0.01% 560
2015
Q1
$921K Sell
7,112
-17
-0.2% -$1.98K ﹤0.01% 600
2014
Q4
$734K Buy
7,129
+1,082
+18% +$107K ﹤0.01% 585
2014
Q3
$548K Buy
+6,047
New +$565K ﹤0.01% 600
2014
Q2
Sell
-4,546
Closed -$381K 749
2014
Q1
$381K Sell
4,546
-4,993
-52% -$411K ﹤0.01% 608
2013
Q4
$834K Hold
9,539
﹤0.01% 631
2013
Q3
$733K Sell
9,539
-60
-0.6% -$4.68K ﹤0.01% 619
2013
Q2
$696 Buy
+9,599
New +$647K ﹤0.01% 609

Other funds holding CI

Loomis, Sayles & Company's CI Position: Q1 2026 in Review

Loomis, Sayles & Company reduced its Cigna (CI) stake by 53% in Q1 2026, selling an estimated $63.4K and leaving 200 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Loomis, Sayles & Company first reported a position in CI in Q2 2013 and has held it in 45 quarters since. The position peaked at $3.53M in Q1 2019. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Loomis, Sayles & Company held 200 shares of Cigna worth $53.4K as of Q1 2026.
  • Loomis, Sayles & Company sold 229 Cigna shares in Q1 2026, an estimated $63.4K.
  • Cigna made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q1 2026, its #616 holding.
  • Loomis, Sayles & Company first reported a position in Cigna in Q2 2013 and has held it in 45 quarters since.
  • Loomis, Sayles & Company's Cigna position peaked at $3.53M in Q1 2019.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.